BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24304373)

  • 1. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.
    Horna P; Pantazopoulos P; Lancet JE; Moscinski LC; Zhang L
    Leuk Lymphoma; 2014 Aug; 55(8):1952-4. PubMed ID: 24304373
    [No Abstract]   [Full Text] [Related]  

  • 2. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia.
    Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA
    Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
    Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
    Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
    [No Abstract]   [Full Text] [Related]  

  • 4. Small, abnormal B lymphoid blast populations in chronic myelogenous leukemia at diagnosis: Does this finding indicate an accelerated course?
    Soma L; Oehler VG; Ding C; Cherian S
    Cytometry B Clin Cytom; 2016 Sep; 90(5):440-8. PubMed ID: 26800237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript.
    Miyashita N; Onozawa M; Suto K; Fujisawa S; Okazaki N; Hidaka D; Ohigashi H; Yasumoto A; Sugita J; Hashimoto D; Matsuno Y; Teshima T
    Intern Med; 2022 Apr; 61(7):1049-1054. PubMed ID: 34511573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible implication of IKAROS gene deletion and BCR-ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience.
    Moschovi M; Adamaki M; Athanasiadou A; Divane A; Karytianou A; Tourkantoni N
    Leuk Lymphoma; 2015; 56(8):2460-2. PubMed ID: 25641431
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma.
    Leone G; La Rocca LM; Teofili L; De Candia E; Landolfi R; Sica S; Zini G; Zollino M; Tabilio A
    Haematologica; 1992; 77(4):311-4. PubMed ID: 1427440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
    Nand S; Barton K
    Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
    [No Abstract]   [Full Text] [Related]  

  • 10. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.
    Stagno F; Stella S; Berretta S; Massimino M; Antolino A; Giustolisi R; Messina A; Di Raimondo F; Vigneri P
    Leuk Res; 2008 Apr; 32(4):673-4. PubMed ID: 17889935
    [No Abstract]   [Full Text] [Related]  

  • 12. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
    Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
    Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
    Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myeloid leukemia: a decade of progress].
    Cervantes F
    Med Clin (Barc); 1990 Jan; 94(1):27-35. PubMed ID: 1692385
    [No Abstract]   [Full Text] [Related]  

  • 17. Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1.
    Xu D; Claudiani S; Naresh K; Mucklow S; Neelakantan P; Yebra E; Apperley JF; Khorashad J; Milojkovic D
    Leuk Lymphoma; 2019 Dec; 60(12):3090-3091. PubMed ID: 31184233
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of small abnormal B-Lymphoblast populations at diagnosis of chronic myelogenous leukemia, BCR-ABL1+: Incidence, phenotypic features, and clinical implications.
    Vrotsos E; Gorgan M; DiGiuseppe JA
    Cytometry B Clin Cytom; 2017 Jul; 92(4):275-278. PubMed ID: 25916436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR-ABL1- and CBFB-MYH11-positive chronic myeloid leukemia presenting with primary blast crisis and marrow fibrosis.
    Kidoguchi K; Kojima K; Yokoo M; Kimura S
    Ann Hematol; 2019 Oct; 98(10):2461-2462. PubMed ID: 31399807
    [No Abstract]   [Full Text] [Related]  

  • 20. Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML.
    Guerrasio A; Martinelli G; Ambrosetti A; Falda M; Paolino F; Rege-Cambrin G; Rosso C; Pignatti PF; Gasparini P; Perona G
    Haematologica; 1991; 76(2):126-30. PubMed ID: 1937170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.